Herein, our clinical data suggested that HMGB3 expression was aberrant in NPC tissues and affected patient outcomes; notably, patients exhibited micronuclei formation and increased HMGB3 expression in the extracellular matrix. This evidence concerns the gene HMGB3 and nasopharyngeal carcinoma.